This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA473826; GEO: GSE115124 |
| Type | Umbrella project |
| Publications | Huang YH et al., "POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.", Genes Dev, 2018 Jul 1;32(13-14):915-928 |
| Grants | - "CSHL CANCER CENTER SUPPORT GRANT" (Grant ID P30 CA045508, National Cancer Institute)
- "BET bromodomain inhibition as targeted therapy in acute myeloid leukemia" (Grant ID R01 CA174793, National Cancer Institute)
|
| Submission | Registration date: 30-May-2018
Cold Spring Harbor Laboratory |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 88 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 88 |
| GEO DataSets | 3 |
POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA473830 | Homo sapiens | POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer [ChIP-seq] (Cold Spring Harbor Laboratory) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA473832 | Homo sapiens | POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer [RNA-seq] (Cold Spring Harbor Laboratory) |
|